Sanofi Stock: How Much Upside Potential Does Wall Street See?
Sanofi (SNY) is a global biopharmaceutical company, headquartered in France, with a market capitalization of $110.7 billion. It offers an expansive product portfolio that offers solutions across disease segments, including multiple sclerosis, immunology, neurology, oncology, cardiovascular diseases, diabetes, vaccines, infectious diseases, and rare disease disorders.